Skip to Content

CTI 103 (Diclofenac Sodium Delayed Release 75 mg)

Pill with imprint CTI 103 is White, Round and has been identified as Diclofenac Sodium Delayed Release 75 mg. It is supplied by Carlsbad Technology, Inc..

Diclofenac is used in the treatment of back pain; osteoarthritis; sciatica; frozen shoulder; ankylosing spondylitis (and more), and belongs to the drug class Nonsteroidal anti-inflammatory drugs. There is positive evidence of human fetal risk during pregnancy. Diclofenac 75 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CTI 103

Diclofenac Sodium Delayed Release

Imprint:
CTI 103
Strength:
75 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Nonsteroidal anti-inflammatory drugs
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Carlsbad Technology, Inc.
Inactive Ingredients:
ferrosoferric oxide
hypromelloses
lactose monohydrate
magnesium stearate
methacrylic acid - methyl methacrylate copolymer (1:1)
microcrystalline cellulose
shellac
povidone
sodium starch glycolate type A potato
magnesium silicate
titanium dioxide
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
42291-0231 AvKare, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide